765
Views
0
CrossRef citations to date
0
Altmetric
Article

Paroxetine can improve primary visual cortex activity in a high-risk mouse model of schizophrenia

, , , , , , , , , , & ORCID Icon show all
Pages 1299-1303 | Received 07 Jan 2020, Accepted 09 Oct 2020, Published online: 22 Oct 2020

References

  • Waters F, Collerton D, Ffytche DH, et al. Visual hallucinations in the psychosis spectrum and comparative information from neurodegenerative disorders and eye disease. Schizophr Bull. 2014;40(Suppl 4):S233–S245.
  • Mittal VA, Gupta T, Keane BP, et al. Visual context processing dysfunctions in youth at high risk for psychosis: resistance to the Ebbinghaus illusion and its symptom and social and role functioning correlates. J Abnorm Psychol. 2015;124(4):953–960.
  • Hebert M, Gagne AM, Paradis ME, et al. Retinal response to light in young nonaffected offspring at high genetic risk of neuropsychiatric brain disorders. Biol Psychiatry. 2010;67(3):270–274.
  • Grano N, Salmijarvi L, Karjalainen M, et al. Early signs of worry: psychosis risk symptom visual distortions are independently associated with suicidal ideation. Psychiatry Res. 2015;225(3):263–267.
  • Clark A. Whatever next? Predictive brains, situated agents, and the future of cognitive science. Behav Brain Sci. 2013;36(3):181–204.
  • Green MF, Hellemann G, Horan WP, et al. From perception to functional outcome in schizophrenia: modeling the role of ability and motivation. Arch Gen Psychiatry. 2012;69(12):1216–1224.
  • Guidotti A, Grayson DR. A neurochemical basis for an epigenetic vision of psychiatric disorders (1994-2009). Pharmacol Res. 2011;64(4):344–349.
  • Fernandes TMP, Silverstein SM, Butler PD, et al. Color vision impairments in schizophrenia and the role of antipsychotic medication type. Schizophr Res. 2019;204:162–170.
  • Silverstein SM. Visual perception disturbances in schizophrenia: a unified model. Nebr Symp Motiv. 2016;63:77–132.
  • Cohen L, Ponchel A, Kas A, et al. Recovery from cortical blindness with mepivacaïne. Ann Clin Transl Neurol. 2019;6(8):1541–1545.
  • Schneier FR, Pomplun M, Sy M, et al. Neural response to eye contact and paroxetine treatment in generalized social anxiety disorder. Psychiatry Res. 2011;194(3):271–278.
  • Parsons B, Roxas A, Jr., Huang YY, et al. Regional studies of serotonin and dopamine metabolism and quantification of serotonin uptake sites in human cerebral cortex. J Neural Transm Gen Sect. 1992;87(1):63–75.
  • Haß K, Bak N, Szycik GR, et al. Deficient prepulse inhibition of the startle reflex in schizophrenia using a cross-modal paradigm. Biol Psychol. 2017;128:112–116.
  • Zieba J, Morris MJ, Weickert CS, et al. Behavioural effects of high fat diet in adult Nrg1 type III transgenic mice. Behav Brain Res. 2020;377:112217.
  • Chen K, Zheng Y, Wei JA, et al. Exercise training improves motor skill learning via selective activation of mTOR. Sci Adv. 2019;5(7):eaaw1888.
  • Forster D, Dal Maschio M, Laurell E, et al. An optogenetic toolbox for unbiased discovery of functionally connected cells in neural circuits. Nat Commun. 2017;8(1):116.
  • Hutchinson EB, Stefanovic B, Koretsky AP, et al. Spatial flow-volume dissociation of the cerebral microcirculatory response to mild hypercapnia. Neuroimage. 2006;32(2):520–530.
  • Silverstein SM, All SD, Kasi R, et al. Increased fusiform area activation in schizophrenia during processing of spatial frequency-degraded faces, as revealed by fMRI. Psychol Med. 2010;40(7):1159–1169.
  • Silverstein SM, Berten S, Essex B, et al. An fMRI examination of visual integration in schizophrenia. J Integr Neurosci. 2009;8(2):175–202.
  • Nagel M, Sprenger A, Nitschke M, et al. Different extraretinal neuronal mechanisms of smooth pursuit eye movements in schizophrenia: an fMRI study. Neuroimage. 2007;34(1):300–309.
  • Allen P, Moore H, Corcoran CM, et al. Emerging temporal lobe dysfunction in people at clinical high risk for psychosis. Front Psychiatry. 2019;10:298.
  • Iwashiro N, Koike S, Satomura Y, et al. Association between impaired brain activity and volume at the sub-region of Broca's area in ultra-high risk and first-episode schizophrenia: a multi-modal neuroimaging study. Schizophr Res. 2016;172(1-3):9–15.
  • Kasparek T, Prikryl R, Schwarz D, et al. Gray matter morphology and the level of functioning in one-year follow-up of first-episode schizophrenia patients. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(8):1438–1446.
  • Stoyanov D. Perspectives in applied neuroscience research - part I. Curr Top Med Chem. 2018;18(19):1619–1620.